Macular Disorders Thesis Topics for MS Ophthalmology

macular diseases thesis topics

This page brings together macular disorders thesis topics for MS Ophthalmology across diabetic macular oedema, age-related macular degeneration, central serous chorioretinopathy, retinal vein occlusion, epiretinal membrane, vitreomacular traction, macular hole, myopic maculopathy, postoperative macular oedema, inflammatory disease and inherited macular disorders. The topics are intended for MS Ophthalmology residents and are framed around designs that can usually be completed within one thesis period using routine retina patients, best corrected visual acuity, fundus examination, photography and optical coherence tomography already available in a teaching hospital. The strongest macular disease research topics for MS Ophthalmology distinguish anatomical OCT biomarkers from functional visual outcomes and define the disease-specific measurement rules before analysis. Once a topic is shortlisted, the MS Ophthalmology macular disorders protocol and MS Ophthalmology macular disorders synopsis should specify the OCT parameters, study-eye rule, treatment status, follow-up interval and primary outcome.

Last reviewed and updated: September 2026 · 2026–27 admissions

Diabetic Macular Oedema

  1. Association of central macular thickness with best corrected visual acuity in treatment-naive diabetic macular oedema: a cross-sectional analytical study
  2. Correlation of duration of diabetes with optical coherence tomography severity markers in diabetic macular oedema: a cross-sectional study
  3. Association of glycated haemoglobin with central macular thickness in patients with diabetic macular oedema: a cross-sectional analytical study
  4. Correlation of subfoveal choroidal thickness with severity of diabetic macular oedema on optical coherence tomography: a cross-sectional study
  5. Association of hyperreflective retinal foci with visual acuity in treatment-naive diabetic macular oedema: a cross-sectional analytical study
  6. Relationship of disorganization of retinal inner layers with visual acuity in diabetic macular oedema: a cross-sectional optical coherence tomography study
  7. Association of subretinal fluid with visual acuity and central macular thickness in diabetic macular oedema: a comparative cross-sectional study
  8. Correlation of serum lipid profile with hard exudate burden in patients with diabetic macular oedema: a cross-sectional analytical study
  9. Agreement between clinical biomicroscopy and optical coherence tomography for detection of diabetic macular oedema: an observer agreement study
  10. Diagnostic accuracy of fundus photography for detecting diabetic macular oedema using optical coherence tomography as reference standard: a diagnostic accuracy study
  11. Association of renal dysfunction with severity of diabetic macular oedema in patients with type 2 diabetes mellitus: a cross-sectional study
  12. Relationship of systemic hypertension with central macular thickness in patients with diabetic macular oedema: a cross-sectional analytical study
  13. Correlation of macular microaneurysm burden with central macular thickness in diabetic macular oedema: a cross-sectional fundus photography study
  14. Association of vitreomacular interface abnormalities with severity of diabetic macular oedema on optical coherence tomography: a cross-sectional study
  15. Visual acuity and central macular thickness after three monthly bevacizumab injections for diabetic macular oedema: a prospective twelve-week study
  16. Visual acuity and central macular thickness after three monthly ranibizumab injections for diabetic macular oedema: a prospective twelve-week study
  17. Predictive value of baseline optical coherence tomography biomarkers for twelve-week visual response to bevacizumab in diabetic macular oedema: a prospective study
  18. Association of diabetic retinopathy severity with optical coherence tomography patterns of diabetic macular oedema: a cross-sectional analytical study
  19. Correlation of macular sensitivity on automated perimetry with central macular thickness in diabetic macular oedema: a cross-sectional study
  20. Association of newly diagnosed diabetes mellitus with severity of presenting diabetic macular oedema compared with known diabetes: a comparative cross-sectional study
  1. Association of drusen burden with best corrected visual acuity in non-neovascular age-related macular degeneration: a cross-sectional analytical study
  2. Correlation of central macular thickness with visual acuity in neovascular age-related macular degeneration: a cross-sectional optical coherence tomography study
  3. Association of subretinal fluid with visual acuity in treatment-naive neovascular age-related macular degeneration: a comparative cross-sectional study
  4. Association of intraretinal fluid with baseline visual acuity in neovascular age-related macular degeneration: a cross-sectional analytical study
  5. Correlation of pigment epithelial detachment height with visual acuity in neovascular age-related macular degeneration: a cross-sectional study
  6. Association of subretinal hyperreflective material with visual acuity in neovascular age-related macular degeneration: a cross-sectional optical coherence tomography study
  7. Relationship of smoking exposure with severity of age-related macular degeneration among patients attending a tertiary hospital: a cross-sectional study
  8. Association of systemic hypertension with neovascular age-related macular degeneration compared with non-neovascular disease: a case-control study
  9. Diagnostic accuracy of Amsler grid abnormalities for detecting neovascular macular changes using optical coherence tomography as reference standard: a diagnostic accuracy study
  10. Agreement between fundus photography and clinical examination for grading age-related macular degeneration severity: an observer agreement study
  11. Correlation of subfoveal choroidal thickness with age-related macular degeneration severity: a comparative cross-sectional optical coherence tomography study
  12. Association of reticular pseudodrusen with visual acuity in non-neovascular age-related macular degeneration: a cross-sectional analytical study
  13. Relationship of geographic atrophy size with best corrected visual acuity in age-related macular degeneration: a cross-sectional fundus photography study
  14. Association of fellow-eye macular abnormalities with neovascular age-related macular degeneration at presentation: a cross-sectional analytical study
  15. Visual acuity and central macular thickness after three monthly bevacizumab injections in treatment-naive neovascular age-related macular degeneration: a prospective study
  16. Predictive value of baseline subretinal fluid for twelve-week visual response to bevacizumab in neovascular age-related macular degeneration: a prospective study
  17. Predictive value of baseline pigment epithelial detachment for twelve-week anatomical response to bevacizumab in neovascular age-related macular degeneration: a prospective study
  18. Association of outer retinal layer disruption with visual acuity in neovascular age-related macular degeneration: a cross-sectional optical coherence tomography study
  19. Correlation of lesion size on fundus photography with visual impairment in neovascular age-related macular degeneration: a cross-sectional analytical study
  20. Clinical profile and optical coherence tomography characteristics of patients presenting with advanced age-related macular degeneration: a retrospective record-based study

Central Serous Chorioretinopathy

  1. Correlation of subretinal fluid height with best corrected visual acuity in acute central serous chorioretinopathy: a cross-sectional analytical study
  2. Association of subfoveal choroidal thickness with central serous chorioretinopathy compared with healthy eyes: a comparative cross-sectional study
  3. Correlation of duration of symptoms with photoreceptor layer disruption in central serous chorioretinopathy: a cross-sectional optical coherence tomography study
  4. Association of corticosteroid exposure with central serous chorioretinopathy among adults attending a tertiary hospital: a case-control study
  5. Association of psychological stress with central serous chorioretinopathy compared with age-matched controls: a case-control questionnaire-based study
  6. Relationship of systemic hypertension with central serous chorioretinopathy among newly diagnosed patients: a cross-sectional analytical study
  7. Correlation of subretinal fluid volume with visual acuity in acute central serous chorioretinopathy: a cross-sectional optical coherence tomography study
  8. Association of pigment epithelial detachment with visual acuity in acute central serous chorioretinopathy: a comparative cross-sectional study
  9. Correlation of outer retinal layer integrity with visual acuity in chronic central serous chorioretinopathy: a cross-sectional study
  10. Comparison of choroidal thickness between acute and chronic central serous chorioretinopathy: a comparative cross-sectional optical coherence tomography study
  11. Association of recurrence history with baseline choroidal thickness in central serous chorioretinopathy: a cross-sectional analytical study
  12. Agreement between clinical examination and optical coherence tomography for detecting residual subretinal fluid in central serous chorioretinopathy: an agreement study
  13. Visual acuity and subretinal fluid reduction over twelve weeks in acute central serous chorioretinopathy managed conservatively: a prospective observational study
  14. Baseline optical coherence tomography predictors of complete subretinal fluid resolution at twelve weeks in acute central serous chorioretinopathy: a prospective study
  15. Association of sleep quality with central serous chorioretinopathy compared with healthy controls: a case-control questionnaire-based study
  16. Correlation of central macular thickness with metamorphopsia severity in central serous chorioretinopathy: a cross-sectional analytical study
  17. Association of smoking with chronicity of central serous chorioretinopathy at presentation: a cross-sectional analytical study
  18. Comparison of macular thickness between affected and fellow eyes in unilateral central serous chorioretinopathy: a comparative cross-sectional study
  19. Association of hyperreflective subretinal deposits with visual acuity in chronic central serous chorioretinopathy: a cross-sectional optical coherence tomography study
  20. Clinical and optical coherence tomography profile of central serous chorioretinopathy among adults presenting to an Indian tertiary hospital: a retrospective study
  1. Correlation of central macular thickness with best corrected visual acuity in retinal vein occlusion-related macular oedema: a cross-sectional study
  2. Comparison of macular thickness and visual acuity between branch and central retinal vein occlusion: a comparative cross-sectional study
  3. Association of systemic hypertension with severity of macular oedema in retinal vein occlusion: a cross-sectional analytical study
  4. Association of diabetes mellitus with central macular thickness in patients with retinal vein occlusion: a cross-sectional analytical study
  5. Correlation of duration of symptoms with visual acuity in retinal vein occlusion-related macular oedema: a cross-sectional study
  6. Association of subretinal fluid with presenting visual acuity in retinal vein occlusion-related macular oedema: a comparative cross-sectional study
  7. Association of hyperreflective retinal foci with visual acuity in retinal vein occlusion-related macular oedema: a cross-sectional optical coherence tomography study
  8. Relationship of disorganization of retinal inner layers with visual acuity in retinal vein occlusion-related macular oedema: a cross-sectional study
  9. Association of outer retinal layer disruption with visual acuity in retinal vein occlusion-related macular oedema: a cross-sectional analytical study
  10. Comparison of optical coherence tomography biomarkers between branch and central retinal vein occlusion-related macular oedema: a comparative cross-sectional study
  11. Visual acuity and central macular thickness after three monthly bevacizumab injections for branch retinal vein occlusion-related macular oedema: a prospective study
  12. Visual acuity and central macular thickness after three monthly bevacizumab injections for central retinal vein occlusion-related macular oedema: a prospective study
  13. Baseline optical coherence tomography predictors of twelve-week visual response to bevacizumab in retinal vein occlusion-related macular oedema: a prospective study
  14. Association of presenting retinal haemorrhage extent with macular oedema severity in branch retinal vein occlusion: a cross-sectional study
  15. Correlation of macular thickness with duration of retinal vein occlusion-related macular oedema before treatment: a cross-sectional analytical study
  16. Association of glaucoma with central retinal vein occlusion among patients presenting with macular oedema: a case-control study
  17. Association of dyslipidaemia with branch retinal vein occlusion among adults attending a tertiary hospital: a case-control study
  18. Agreement between clinical biomicroscopy and optical coherence tomography for detecting macular oedema in retinal vein occlusion: an observer agreement study
  19. Comparison of macular oedema severity between ischaemic and non-ischaemic retinal vein occlusion: a comparative cross-sectional optical coherence tomography study
  20. Clinical and optical coherence tomography profile of retinal vein occlusion-related macular oedema in an Indian tertiary hospital: a retrospective study

Epiretinal Membrane and Vitreomacular Traction

  1. Correlation of central macular thickness with best corrected visual acuity in idiopathic epiretinal membrane: a cross-sectional analytical study
  2. Association of epiretinal membrane stage with visual acuity using optical coherence tomography grading: a cross-sectional analytical study
  3. Correlation of inner retinal distortion with metamorphopsia severity in idiopathic epiretinal membrane: a cross-sectional study
  4. Association of outer retinal layer disruption with visual acuity in idiopathic epiretinal membrane: a cross-sectional optical coherence tomography study
  5. Relationship of ectopic inner foveal layers with visual acuity in idiopathic epiretinal membrane: a cross-sectional analytical study
  6. Comparison of macular thickness between eyes with epiretinal membrane and unaffected fellow eyes: a comparative cross-sectional study
  7. Association of age with anatomical severity of idiopathic epiretinal membrane on optical coherence tomography: a cross-sectional analytical study
  8. Agreement between clinical examination and optical coherence tomography for staging epiretinal membrane: an observer agreement study
  9. Correlation of central macular thickness with metamorphopsia in vitreomacular traction syndrome: a cross-sectional analytical study
  10. Association of vitreomacular adhesion width with visual acuity in symptomatic vitreomacular traction syndrome: a cross-sectional study
  11. Relationship of foveal cystic changes with visual acuity in vitreomacular traction syndrome: a comparative cross-sectional study
  12. Comparison of visual acuity between focal and broad vitreomacular adhesion in symptomatic vitreomacular traction: a comparative cross-sectional study
  13. Association of vitreomacular traction severity with outer retinal disruption on optical coherence tomography: a cross-sectional analytical study
  14. Correlation of macular thickness with symptom duration in patients with vitreomacular traction syndrome: a cross-sectional study
  15. Association of posterior vitreous detachment status with epiretinal membrane severity: a cross-sectional optical coherence tomography study
  16. Comparison of macular morphology in idiopathic and secondary epiretinal membranes: a comparative cross-sectional optical coherence tomography study
  17. Association of diabetic retinopathy with secondary epiretinal membrane severity compared with idiopathic epiretinal membrane: a comparative cross-sectional study
  18. Correlation of preoperative optical coherence tomography biomarkers with six-week visual outcome after epiretinal membrane surgery: a prospective observational study
  19. Change in central macular thickness and visual acuity six weeks after epiretinal membrane surgery: a prospective observational study
  20. Clinical and optical coherence tomography profile of vitreomacular interface disorders in adults attending a tertiary hospital: a cross-sectional study

Macular Hole

  1. Correlation of minimum macular hole diameter with best corrected visual acuity in idiopathic full-thickness macular hole: a cross-sectional study
  2. Association of macular hole stage with presenting visual acuity in idiopathic full-thickness macular hole: a cross-sectional analytical study
  3. Correlation of basal macular hole diameter with symptom duration in idiopathic full-thickness macular hole: a cross-sectional study
  4. Association of macular hole height with visual acuity in idiopathic full-thickness macular hole: a cross-sectional optical coherence tomography study
  5. Relationship of macular hole index with presenting visual acuity in idiopathic full-thickness macular hole: a cross-sectional analytical study
  6. Association of outer retinal layer disruption with visual acuity in idiopathic full-thickness macular hole: a cross-sectional study
  7. Comparison of optical coherence tomography parameters between small and large idiopathic full-thickness macular holes: a comparative cross-sectional study
  8. Association of posterior vitreous status with stage of idiopathic full-thickness macular hole: a cross-sectional optical coherence tomography study
  9. Comparison of visual acuity between traumatic and idiopathic full-thickness macular holes: a comparative cross-sectional study
  10. Comparison of optical coherence tomography morphology between traumatic and idiopathic full-thickness macular holes: a comparative cross-sectional study
  11. Correlation of traumatic macular hole size with visual acuity following blunt ocular trauma: a cross-sectional analytical study
  12. Association of duration of traumatic macular hole with outer retinal disruption: a cross-sectional optical coherence tomography study
  13. Agreement between clinical examination and optical coherence tomography for diagnosing full-thickness macular hole: an observer agreement study
  14. Diagnostic accuracy of clinical biomicroscopy for full-thickness macular hole using optical coherence tomography as reference standard: a diagnostic accuracy study
  15. Association of fellow-eye vitreomacular interface abnormalities with idiopathic full-thickness macular hole: a cross-sectional study
  16. Correlation of preoperative macular hole diameter with six-week visual acuity after macular hole surgery: a prospective observational study
  17. Association of baseline optical coherence tomography parameters with anatomical closure six weeks after macular hole surgery: a prospective study
  18. Change in visual acuity and central foveal morphology six weeks after surgery for idiopathic full-thickness macular hole: a prospective study
  19. Comparison of macular hole characteristics between younger and older adults with idiopathic full-thickness macular hole: a comparative cross-sectional study
  20. Clinical and optical coherence tomography profile of full-thickness macular holes presenting to an Indian tertiary hospital: a retrospective observational study

Myopic Maculopathy

  1. Association of axial length with severity of myopic maculopathy in adults with high myopia: a cross-sectional analytical study
  2. Correlation of spherical equivalent refractive error with myopic maculopathy severity in highly myopic eyes: a cross-sectional study
  3. Association of subfoveal choroidal thickness with visual acuity in high myopia: a cross-sectional optical coherence tomography study
  4. Correlation of axial length with subfoveal choroidal thickness in adults with high myopia: a cross-sectional analytical study
  5. Association of myopic macular degeneration grade with best corrected visual acuity in highly myopic eyes: a cross-sectional study
  6. Comparison of macular thickness between highly myopic eyes and age-matched emmetropic eyes: a comparative cross-sectional optical coherence tomography study
  7. Association of posterior staphyloma with visual impairment in adults with pathologic myopia: a cross-sectional analytical study
  8. Relationship of lacquer cracks with visual acuity in patients with pathologic myopia: a cross-sectional fundus photography study
  9. Association of patchy macular atrophy with visual acuity in pathologic myopia: a cross-sectional analytical study
  10. Association of myopic traction maculopathy with axial length in highly myopic eyes: a cross-sectional optical coherence tomography study
  11. Correlation of foveoschisis severity with visual acuity in myopic traction maculopathy: a cross-sectional analytical study
  12. Association of epiretinal membrane with severity of myopic traction maculopathy: a cross-sectional optical coherence tomography study
  13. Relationship of vitreomacular traction with foveoschisis severity in highly myopic eyes: a cross-sectional analytical study
  14. Comparison of macular morphology in highly myopic eyes with and without posterior staphyloma: a comparative cross-sectional study
  15. Diagnostic accuracy of fundus photography for grading myopic maculopathy using clinical retinal examination as reference standard: a diagnostic accuracy study
  16. Agreement between two ophthalmologists for photographic grading of myopic maculopathy in highly myopic eyes: an inter-observer agreement study
  17. Association of age with progression grade of myopic maculopathy at presentation in highly myopic adults: a cross-sectional analytical study
  18. Correlation of macular atrophy area with visual acuity in pathologic myopia: a cross-sectional fundus photography study
  19. Association of myopic choroidal neovascularisation with visual impairment among adults with pathologic myopia: a comparative cross-sectional study
  20. Clinical and optical coherence tomography profile of myopic maculopathy among highly myopic patients attending a tertiary hospital: a cross-sectional study

Postoperative and Pseudophakic Macular Oedema

  1. Incidence of optical coherence tomography-detected macular oedema six weeks after uncomplicated cataract surgery: a prospective observational study
  2. Change in central macular thickness from preoperative baseline to six weeks after uncomplicated cataract surgery: a prospective observational study
  3. Association of diabetes mellitus with central macular thickness six weeks after uncomplicated cataract surgery: a prospective comparative study
  4. Comparison of postoperative macular thickness between diabetic patients without retinopathy and non-diabetic patients after cataract surgery: a prospective study
  5. Association of preoperative diabetic retinopathy severity with macular thickness six weeks after cataract surgery: a prospective observational study
  6. Correlation of postoperative central macular thickness with visual acuity six weeks after cataract surgery: a prospective analytical study
  7. Association of intraoperative posterior capsular rupture with macular oedema six weeks after cataract surgery: a prospective observational study
  8. Comparison of macular thickness after phacoemulsification and manual small-incision cataract surgery at six weeks: a prospective comparative study
  9. Comparison of visual acuity and macular thickness after uncomplicated and complicated cataract surgery at six weeks: a prospective comparative study
  10. Association of preoperative macular thickness with postoperative macular oedema six weeks after cataract surgery: a prospective analytical study
  11. Diagnostic accuracy of clinical examination for pseudophakic macular oedema using optical coherence tomography as reference standard: a diagnostic accuracy study
  12. Agreement between fundus biomicroscopy and optical coherence tomography for detecting macular oedema after cataract surgery: an observer agreement study
  13. Association of postoperative anterior chamber inflammation with macular thickness six weeks after cataract surgery: a prospective analytical study
  14. Relationship of surgical duration with central macular thickness six weeks after manual small-incision cataract surgery: a prospective observational study
  15. Association of ultrasound energy used during phacoemulsification with macular thickness six weeks after surgery: a prospective observational study
  16. Comparison of macular thickness after cataract surgery in eyes with and without epiretinal membrane: a prospective comparative study
  17. Visual acuity and central macular thickness at six and twelve weeks in pseudophakic macular oedema treated with topical therapy: a prospective study
  18. Baseline optical coherence tomography predictors of twelve-week visual recovery in pseudophakic macular oedema: a prospective observational study
  19. Association of mature cataract at presentation with postoperative macular thickness six weeks after surgery: a prospective analytical study
  20. Clinical and optical coherence tomography profile of pseudophakic macular oedema presenting to a tertiary hospital: a retrospective observational study

Inflammatory and Infectious Macular Disorders

  1. Correlation of central macular thickness with visual acuity in uveitic macular oedema: a cross-sectional analytical study
  2. Association of uveitis anatomical type with severity of macular oedema on optical coherence tomography: a cross-sectional study
  3. Association of subretinal fluid with visual acuity in uveitic macular oedema: a comparative cross-sectional optical coherence tomography study
  4. Relationship of duration of uveitis with outer retinal layer disruption in uveitic macular oedema: a cross-sectional analytical study
  5. Association of vitreous inflammation severity with central macular thickness in uveitic macular oedema: a cross-sectional study
  6. Comparison of macular thickness between infectious and non-infectious uveitis with macular oedema: a comparative cross-sectional study
  7. Association of ocular tuberculosis with macular oedema among patients with posterior uveitis: a cross-sectional analytical study
  8. Optical coherence tomography characteristics and visual acuity in serpiginous-like choroiditis involving the macula: a cross-sectional study
  9. Correlation of macular lesion size with visual acuity in healed toxoplasma retinochoroiditis: a cross-sectional fundus photography study
  10. Association of macular involvement with visual impairment in ocular toxoplasmosis compared with extramacular disease: a comparative cross-sectional study
  11. Optical coherence tomography characteristics of macular involvement in dengue-associated retinopathy and their correlation with visual acuity: a cross-sectional study
  12. Association of macular oedema with visual impairment in patients with dengue-associated retinopathy: a comparative cross-sectional study
  13. Clinical and optical coherence tomography profile of macular involvement in human immunodeficiency virus-associated retinopathy: a cross-sectional study
  14. Association of immune status with macular abnormalities in patients with human immunodeficiency virus infection: a cross-sectional analytical study
  15. Correlation of central macular thickness with visual acuity in intermediate uveitis-associated macular oedema: a cross-sectional study
  16. Association of epiretinal membrane with visual impairment in chronic uveitis: a comparative cross-sectional optical coherence tomography study
  17. Visual acuity and central macular thickness after twelve weeks of treatment for non-infectious uveitic macular oedema: a prospective observational study
  18. Baseline optical coherence tomography predictors of twelve-week visual improvement in treated uveitic macular oedema: a prospective observational study
  19. Agreement between clinical examination and optical coherence tomography for detecting uveitic macular oedema: an observer agreement study
  20. Clinical profile and causes of inflammatory macular oedema among patients attending an Indian tertiary uveitis clinic: a retrospective study

Macular Dystrophies and Miscellaneous Macular Disorders

  1. Correlation of central macular thickness with best corrected visual acuity in patients with inherited macular dystrophy: a cross-sectional study
  2. Association of outer retinal layer disruption with visual acuity in Stargardt disease: a cross-sectional optical coherence tomography study
  3. Correlation of macular atrophy area with visual acuity in Stargardt disease: a cross-sectional fundus photography study
  4. Association of disease duration with macular atrophy severity in Stargardt disease: a cross-sectional analytical study
  5. Comparison of central macular thickness between Stargardt disease and age-matched healthy eyes: a comparative cross-sectional study
  6. Association of vitelliform lesion stage with visual acuity in adult-onset vitelliform macular dystrophy: a cross-sectional optical coherence tomography study
  7. Correlation of lesion size with visual acuity in adult-onset vitelliform macular dystrophy: a cross-sectional analytical study
  8. Association of outer retinal disruption with visual acuity in pattern macular dystrophy: a cross-sectional optical coherence tomography study
  9. Clinical and optical coherence tomography profile of inherited macular dystrophies presenting to an Indian tertiary hospital: a retrospective observational study
  10. Agreement between clinical diagnosis and optical coherence tomography classification of inherited macular dystrophies: an observer agreement study
  11. Correlation of solar maculopathy lesion size with visual acuity after acute solar exposure: a cross-sectional optical coherence tomography study
  12. Association of duration since solar exposure with outer retinal recovery in solar maculopathy at twelve weeks: a prospective observational study
  13. Correlation of traumatic macular changes with visual acuity following blunt ocular injury: a cross-sectional optical coherence tomography study
  14. Association of commotio retinae involving the fovea with visual impairment after blunt ocular trauma: a comparative cross-sectional study
  15. Optical coherence tomography characteristics and visual outcomes at twelve weeks in traumatic maculopathy after blunt ocular injury: a prospective observational study
  16. Association of tamoxifen exposure duration with macular crystalline deposits among treated patients: a cross-sectional analytical study
  17. Comparison of macular thickness between hydroxychloroquine-exposed patients and matched unexposed controls: a comparative cross-sectional optical coherence tomography study
  18. Correlation of macular optical coherence tomography abnormalities with visual acuity in patients with hydroxychloroquine exposure: a cross-sectional analytical study
  19. Diagnostic accuracy of fundus examination for detecting hydroxychloroquine-related macular abnormalities using optical coherence tomography as reference standard: a diagnostic accuracy study
  20. Clinical and optical coherence tomography spectrum of miscellaneous macular disorders presenting to an Indian tertiary ophthalmology department: a retrospective observational study

Not the ophthalmology subspeciality you need? Macular disorders is one section of our full ophthalmology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.

Check all Ophthalmology Thesis Topics →

📌 Updated for 2026–2027 MS Ophthalmology Macular Disorders admissions

The list was reviewed for feasibility in departments where macular research is based mainly on clinical examination, visual acuity assessment, fundus photography and routine OCT.

  • Many topics can be completed with spectral-domain OCT, fundus examination and best corrected visual acuity; fluorescein angiography, OCT angiography or advanced image analysis is not essential for most resident projects.
  • Cross-sectional analytical, comparative, diagnostic-accuracy and short prospective follow-up designs are usually more practical than long progression studies requiring repeated injections or several years of observation.
  • Publication potential is strongest when OCT biomarkers are defined in advance, automated segmentation is checked manually and anatomical change is analysed separately from visual outcome.
Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already have your thesis title?

Generate the full macular disorders protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside macular disorders protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Macular disorders research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the macular disorders research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the macular disorders research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a macular disorders research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A macular disorders IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning macular disorders research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the macular disorders research proposal is the document assessed at the start of it.

Kuwait — KIMS. A macular disorders study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the macular disorders proposal follows the same structure throughout.

Generate a macular disorders research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A macular disorders dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full macular disorders research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about a macular disorders PhD or MMed proposal →

🔥 Trending research areas in Macular Disorders for 2026–27

Macular research is increasingly focused on disease-specific imaging biomarkers and on explaining why anatomical and visual outcomes do not always move together.

  • OCT biomarkers beyond central thickness: outer retinal integrity, disorganisation of retinal inner layers, hyperreflective foci, subretinal fluid and pigment epithelial detachment are useful because they may explain vision better than thickness alone.
  • Short-term anti-VEGF response prediction: baseline OCT features in diabetic macular oedema, neovascular age-related macular degeneration and retinal vein occlusion can be studied against fixed early anatomical and visual outcomes.
  • Vitreomacular interface disorders: epiretinal membrane, vitreomacular traction and macular hole measurements offer practical structure-function projects using routinely acquired OCT.
  • High myopia and macular morphology: posterior staphyloma, foveoschisis, choroidal thinning and myopic macular atrophy are important because highly myopic anatomy also creates interpretation and segmentation challenges.

Protocol and synopsis guidance

What a Macular Disorders protocol must contain

Define the macular diagnosis and treatment status precisely. Diabetic macular oedema, neovascular age-related macular degeneration, central serous chorioretinopathy, retinal vein occlusion-related oedema, epiretinal membrane and macular hole should each have prespecified clinical and OCT criteria. State whether patients are treatment-naive, previously treated or being followed after surgery or injection.

Prespecify the OCT biomarkers. Central macular thickness, subretinal fluid, intraretinal fluid, pigment epithelial detachment, disorganisation of retinal inner layers, outer retinal disruption and other features should be defined before image review. Automated segmentation should be inspected because oedema, traction, high myopia and distorted foveal anatomy can produce erroneous measurements.

Separate anatomy from function. Best corrected visual acuity and OCT morphology answer different questions. A study may examine their association, but it should not assume that reduced thickness means improved vision or that a normal central thickness excludes important macular pathology.

Fix the study eye and time point. State whether one or both eyes may be included, how bilateral disease will be handled statistically, and whether imaging is performed at baseline, after a defined injection schedule, after surgery or at a fixed postoperative interval.

Macular Disorders synopsis versus Macular Disorders protocol

The synopsis gives the compact scientific plan. It should identify the macular condition, principal OCT or clinical biomarker, comparison or exposure, primary visual or anatomical outcome, study design and planned analysis.

The protocol provides the imaging rules. It should specify OCT device, scan pattern, signal-quality threshold, segmentation review, biomarker definitions, visual acuity method, treatment status, study-eye selection, masking where relevant and follow-up timing.

Disease-specific definitions matter. A central thickness value has a different clinical meaning in diabetic macular oedema, central serous chorioretinopathy, epiretinal membrane and high myopia. The protocol should therefore avoid using a generic OCT threshold across biologically different macular disorders unless that threshold is validated for the intended condition.

Sample size and statistical analysis

Calculate sample size from the primary outcome. Correlation studies may use the expected relationship between an OCT biomarker and visual acuity, comparative studies use the anticipated difference between groups, diagnostic-accuracy studies use expected sensitivity or specificity, and prospective response studies use the expected change in the principal visual or anatomical outcome.

Do not automatically count two eyes as independent participants. Fellow eyes share systemic and genetic factors and their measurements are correlated. Use one prespecified study eye, an appropriate paired analysis or a model that accounts for clustering when both eyes are included.

Match the analysis to the imaging question. Correlation does not establish agreement or prediction. Multivariable models may be needed when baseline visual acuity, disease duration, treatment history, central macular thickness and specific OCT biomarkers jointly influence outcome. Prospective studies should use fixed follow-up intervals and should prespecify how missing scans, poor-quality OCT and segmentation errors will be handled.

Frequently Asked Questions – Macular Disorders Thesis Topics (2026–27)

1. How do I choose a feasible Macular Disorders thesis topic?

For 2026–2027 admissions, choose a macular condition with adequate case volume and an OCT outcome that is recorded consistently. Diabetic macular oedema, age-related macular degeneration, central serous chorioretinopathy, retinal vein occlusion-related oedema and vitreomacular interface disease are generally more feasible than very rare macular dystrophies. Prefer one primary OCT or visual outcome and a follow-up interval that can be completed before dissertation submission.

2. Which study designs are commonly accepted for Macular Disorders thesis work?

Useful designs include cross-sectional analytical studies, comparative cross-sectional studies, correlation studies, diagnostic-accuracy studies, agreement studies, case-control studies, retrospective record-based studies and short prospective observational follow-up after routine treatment or surgery. The design should follow the clinical question and available case volume.

3. What should I settle with my guide before finalising a Macular Disorders topic?

Settle the exact diagnosis, treatment-naive or previously treated status, study-eye rule, OCT device and scan protocol, biomarker definitions, visual acuity method, primary outcome and follow-up point. For treatment-response work, also settle whether the injection or surgical regimen is sufficiently standardised to allow meaningful comparison.

4. How should I handle OCT measurements and segmentation errors?

Do not rely only on exported automated thickness values. Review scan quality and segmentation lines, record whether manual correction is permitted, and define how poor-quality scans will be repeated or excluded. High myopia, oedema, epiretinal membrane, macular holes, pigment epithelial detachments and marked subretinal fluid can distort automated boundaries and produce misleading thickness measurements.

5. What is the difference between a Macular Disorders synopsis and a Macular Disorders protocol?

The synopsis summarises the question, rationale, objectives, design, principal OCT or clinical measurements and analysis. The protocol gives the operating details, including diagnosis criteria, imaging technique, biomarker definitions, scan-quality rules, study-eye selection, visual acuity assessment, treatment status, follow-up timing, missing-data handling and statistical methods.

6. What ethical issues are important in Macular Disorders research?

Prospective studies require informed consent, and children require guardian consent with age-appropriate assent from about seven years where relevant. Record-based or retrospective OCT studies may seek a waiver of consent when permitted by the ethics committee. Research should not add unnecessary scans, angiography, contrast, injections or treatment delay beyond standard care. Separate consent should be obtained for identifiable fundus photographs or video, and OCT, fundus camera and DICOM-derived exports should be anonymised. The protocol should also define how incidental findings such as new choroidal neovascularisation, macular hole, significant traction, retinal vascular occlusion or unexpectedly severe macular oedema will be escalated for clinical management.

7. Can central macular thickness be used as a surrogate for visual acuity?

Not reliably across all macular disorders. Central macular thickness and visual acuity are related in some conditions, but vision also depends on outer retinal integrity, foveal architecture, disorganisation of retinal inner layers, atrophy, fibrosis, chronicity and other disease-specific features. A protocol should therefore analyse anatomical and functional outcomes separately and avoid claiming that a reduction in thickness automatically represents equivalent visual recovery.

8. Can a Macular Disorders thesis also support PhD or Gulf board research pathways?

Yes, but the expected scope differs. A PhD proposal generally requires a broader research gap, stronger methodological justification and a larger programme of work than an MS dissertation. An MS synopsis is usually centred on one feasible dissertation question. SCFHS and Saudi Board trainees may also complete a mandatory board research project, while Arab Board of Health Specializations and DHP, DHA, DOH or MOHAP-linked programmes may use separate proposal, ethics and submission pathways. The scientific topic may overlap, but the document should be written for the intended programme.

9. When should I register my Macular Disorders thesis topic?

Register after confirming adequate case volume, reliable access to OCT and the required retinal imaging, guide agreement on the disease definition and primary outcome, and a follow-up interval that fits the dissertation timeline. Prospective recruitment or research-specific imaging should begin only after the required institutional and ethics approvals are complete.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol
Don`t copy text!
Generate Thesis Protocol / Synopsis
×